Institut Georges Lopez (IGL)
↗Lissieu, France
Institut Georges Lopez (IGL) is a leading medical technology company specializing in the preservation and transport of donor organs and tissues for transplantation. Founded in 2003, the company is dedicated to improving transplant success rates through innovative static cold storage solutions and dynamic machine perfusion technologies.
IGL provides a comprehensive portfolio of products for abdominal and thoracic organs, including its flagship IGL-1 solution and the RM4 renal perfusion system. The company operates globally with subsidiaries in North America (Waters Medical Systems), Latin America, Italy, and Spain, serving over 300 medical centers worldwide.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Organ Transplantation Technologies
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:2003
Ownership:private
Status:operating
FUNDING
Stage:Private Equity
Total Raised:$48M
Investors:Kartesia, Lopez Family
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Organ Preservation Solutions, Hypothermic Machine Perfusion, Pulsatile Perfusion
Active Trials:2
Trial Phases:Phase 4: 2
FDA Approvals:5
EMA Approvals:6
CORPORATE STRUCTURE
Parent Company:Groupe Cair (I-CAIR Group)
Subsidiaries:Waters Medical Systems LLC (USA), IGL America Latina (Brazil), IGL Italia SRL, IGL Spain
Key Partnerships:Sanofi Genzyme (Acquired Celsior solution), Paul Brousse Hospital (Clinical research)
COMPETITION
Position:Leader
Competitors:XVIVO Perfusion, TransMedics, OrganOx, Paragonix Technologies, Bridge to Life, Organ Recovery Systems
LEADERSHIP
Key Executives:
Alexandre Lopez - CEO
Matthieu Prouteau - VP Quality & Head Pharmacist
François Michelon - MD, Waters Medical Systems
Scientific Founders:Georges Antoine Lopez
LINKS
Website:igl-transplantation.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Institut Georges Lopez (IGL). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.